Comparing pain relief methods after breast surgery: a study on new and traditional approaches

Comparing post-lumpectomy analgesia using enhanced recovery after surgery (ERAS) protocol with and without liposomal bupivacaine: randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN85101944

Enrollment

200

Registered

2024-10-15

Start date

2023-04-21

Completion date

Unknown

Last updated

2024-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Use of bupivacaine hydrochloride during lumpectomy surgery Surgery

Interventions

Patients were randomized in a 1:1 ratio to either the intervention group Bupivacaine Liposomal with Bupivacaine Hydrochloride (LB-BH) or Bupivacaine Hydrochloride alone (BH) using a clinical trial ra

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adults over the age of 18 who undergo lumpectomies and able to consent

Exclusion criteria

Exclusion criteria: 1. Patients undergoing any other procedures other than lumpectomies 2. Patients who are getting lumpectomies with any other procedures

Design outcomes

Primary

Measure	Time frame
Pain measured using NRS on day 2 and day 9 post surgery	—

Secondary

Measure	Time frame
Adjunctive opioid use, pain-related ED visits, office calls, requests for pain scripts measured using patient records after day 9 post surgery	—

Countries

United States of America

Contacts

Public ContactIrada Mamukadze

Irada.Mamukadze@umhsparrow.org+1 9372191095

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026